1 min read

Veristat's President Speaks at 3rd Annual Chief Medical Officer Summit

JoAnn Vormschlag : Published April 30, 2015 Updated April 4, 2024

3RD ANNUAL CHIEF MEDICAL OFFICER SUMMIT

May 4-5, 2015 | Battery Wharf Hotel | Boston, MA

Veristat President, John Balser, PhD speaks on

Building Successful Clinical Trials

Join Veristat at the

3rd Annual Chief Medical

Officer Summit

Use Veristat sponsor code VER25 to receive a 25% discount

John Balser, PhD, President, Founder, and Chief Biostatistician at Veristat will be speaking at the 3rd Annual Chief Medical Officer Summit on Building Successful Trials in a small company. In this session, panelists will examine the positives and negatives of implementing design strategies and the best practices in deploying them. More specifically:

Adaptive design (Not just dose change)
Determining endpoints
Trial design strategies
Navigating regulatory landmines
Regulatory POV on changes to trial design

A full-service CRO with over 700 clinical studies under its belt and numerous successful submissions and regulatory approvals, Veristat helps advance sponsor compounds through each phase of the clinical development process. Veristat supports some of the most innovative products today and has offices in Boston, San Francisco and Montreal. As a sponsor of the program, Veristat is able to offer a 25% discount to attend the program. Register here with the code VER25. Schedule a time to talk with a member of the Veristat Executive Leadership team by contacting JoAnn Eckhoff, Client Engagement Manager, at joann.eckhoff@veristat.com or call 617-901-0408.

Featured Speakers

Drug Development Keynote	Physician CEO Keynote	CEO POV	Chair	Building Successful Trials

Ken Getz, MBA Director of Sponsored Research Tufts CSDD	David Schenkein, MD CEO Agios	Leslie Williams, MBA CEO ImmusanT	Lee Allen, MD, PhD CMO Spectrum Pharmaceuticals	John Balser, PhD President, Founder and Chief Biostatistician, Veristat